|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003364,
umls-concept:C0025320,
umls-concept:C0087111,
umls-concept:C0392747,
umls-concept:C0443172,
umls-concept:C0455825,
umls-concept:C0681842,
umls-concept:C0752046,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-12-22
|
|
pubmed:abstractText |
Our aim was to determine whether the change in left ventricular (LV) mass in response to antihypertensive treatment could be predicted by multivariate analysis of single nucleotide polymorphisms (SNPs) in candidate genes reflecting pathways likely to be involved in blood pressure control.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensinogen,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B,
http://linkedlifedata.com/resource/pubmed/chemical/Atenolol,
http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta-2,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/irbesartan
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0263-6352
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2321-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15614026-Adrenergic beta-Antagonists,
pubmed-meshheading:15614026-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:15614026-Angiotensinogen,
pubmed-meshheading:15614026-Antihypertensive Agents,
pubmed-meshheading:15614026-Apolipoproteins B,
pubmed-meshheading:15614026-Atenolol,
pubmed-meshheading:15614026-Biphenyl Compounds,
pubmed-meshheading:15614026-Blood Pressure,
pubmed-meshheading:15614026-Double-Blind Method,
pubmed-meshheading:15614026-Echocardiography,
pubmed-meshheading:15614026-Female,
pubmed-meshheading:15614026-Genotype,
pubmed-meshheading:15614026-Humans,
pubmed-meshheading:15614026-Hypertension,
pubmed-meshheading:15614026-Hypertrophy, Left Ventricular,
pubmed-meshheading:15614026-Male,
pubmed-meshheading:15614026-Middle Aged,
pubmed-meshheading:15614026-Multivariate Analysis,
pubmed-meshheading:15614026-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:15614026-Pharmacogenetics,
pubmed-meshheading:15614026-Polymorphism, Single Nucleotide,
pubmed-meshheading:15614026-Predictive Value of Tests,
pubmed-meshheading:15614026-Receptors, Adrenergic, beta-2,
pubmed-meshheading:15614026-Tetrazoles
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment.
|
|
pubmed:affiliation |
Department of Medical Sciences, Uppsala University, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
